Lead Hopping
Lead Hopping is a drug discovery strategy that identifies novel bioactive compounds by replacing a lead compound’s core scaffold with structurally distinct yet functionally similar moieties, thereby maintaining desired biological activity while enabling significant structural divergence.
52
Publications
2.9K
Citations
445
Authors
116
Institutions
Publications per year
2017–2026
21
Parents
52
Finding Complex Biological Relationships in Recent PubMed Articles Using Bio-LDA
Huijun Wang, Ying Ding, Jie Tang et al. · PLoS ONE · 2011 · 97 citations · Full text
1–5 of 52
445
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 445
116

Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
2 h-index
13 publications
420 citations

Institute of Cancer Research
London, United Kingdom
2 h-index
5 publications
1.3K citations
University of Oxford
Oxford, United Kingdom
2 h-index
3 publications
313 citations
Novartis (Switzerland)
Basel, Switzerland
2 h-index
12 publications
693 citations
AstraZeneca (United States)
Wilmington, United States
2 h-index
11 publications
322 citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
2 h-index
21 publications
507 citations
Novartis Institutes for BioMedical Research
Basel, Switzerland
2 h-index
12 publications
693 citations
Rega Institute for Medical Research
Leuven, Belgium
2 h-index
8 publications
318 citations
1–8 of 116
12 publications · 1.5K citations
12
h-index
9 publications · 239 citations
9
h-index
JCIM · 8 publications · 206 citations
8
h-index
5 publications · 156 citations
4
h-index
4 publications · 89 citations
4
h-index
1–5